Robert F. Day

Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9<i>H</i>-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist

David A. Griffith, John R. Hadcock, Shawn C. Black et al. · Journal of Medicinal Chemistry · 2008 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

New bicyclic cannabinoid receptor-1 (CB1-R) antagonists

Philip A. Carpino, David A. Griffith, Subas M. Sakya et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists

Richard Chesworth, Michael P. Zawistoski, Bruce A. Lefker et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 38 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +12

Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity

Jennifer Lafontaine, Robert F. Day, Joe Dibrino et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12